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Available online 13 June 2012Abstract Recent studies demonstrated that mature atrocytes have the capacity for de-differentiating into neural stem/
progenitor cells (NSPCs) in vitro and in vivo. However, it is still unknownwhat signals endow astroglial cells with a de-differentiation
potential. Furthermore, the signaling molecules and underlying mechanism that confer astrocytes with the competence of NSPC
phenotypes have not been completely elucidated. Here, we found that sonic hedgehog (Shh) production in astrocytes following
mechanical injury was significantly elevated, and that incubation of astrocyes with the injured astrocyte conditionedmedium (ACM)
causes astrocytes to gradually lose their immunophenotypical profiles, and acquire NSPC characteristics, as demonstrated by down-
regulation of typical astrocytic markers (GFAP and S100) and up-regulation of markers that are generally expressed in NSCs, (nestin,
Sox2, and CD133). ACM treated astrocytes exhibit self-renewal capacity and multipotency similar to NSPCs. Concomitantly, in
addition to Ptc, there was a significant up-regulation of the Shh downstream signal components Gli2 and Cyclin D1 which are
involved in cell proliferation, dramatic changes in cell morphology, and the disruption of cell-cycle G1 arrest. Conversely, the
depletion of Shh by administration of its neutralizing antibody (Shh n-Ab) effectively inhibited the de-differentiation process.
Strikingly, Shh alone had little effect on astrocyte de-differentiation to NSPCs. These data above suggest that Shh is a key
instructive molecule while other molecules secreted from insulted astrocytes may synergistically promote the de-differentiation
event.
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The transplantation of neural stem cells is a promising strategy
in restoration of lost functions of injured central nervous system
(CNS). However, a pronounced immune rejection after
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number of NSPCs pose a major challenge in therapeutic
application. Therefore, seeking an autologous cell pool is
essential for developing therapeutic strategies to treat the
traumatic CNS injury. Astrocytes are ubiquitous cells found
throughout the CNS. Compelling evidence indicates that
astrocytes possess de-differentiation potential (Steindler
and Laywell, 2003; Lang et al., 2004; Itoh et al., 2006; Sharif
et al., 2007; Yang et al., 2009, 2010, 2011; Costa et al.,
2010; Sher et al., 2011; Moon et al., 2011). This unique
property of astrocytes makes them a particularly attractive
source of cells for cell-replacement therapy. However,
maintenance of NSPC characteristics and inefficient gener-
ation of NSPCs from de-differentiated astrocytes remain as
prominent problems in their use in cell-replacement
therapy. The factors that efficiently induce astrocyte de-
differentiation into NSPCs remain obscure.
Sonic hedgehog (Shh), a paracrine/autocrine morphogen,
plays critical roles in regulating the expression of genes involved
in cell proliferation, progenitor cell renewal, cell lineage
specification, and tissue regeneration in the organs of various
species (Ahn and Joyner, 2005; Chari and McDonnell, 2007;
Galvin et al., 2007). For example, self-renewal of neurosphere-
forming stem cells in adult mouse forebrain requires the
presence of Shh (Palma et al., 2005; Huang et al., 2010). In
mouse retina, Shh stimulates progenitor cell proliferation and
diversification (Ingham and McMahon, 2001; Lang et al., 2004;
Jiang and Hui, 2008; Wall et al., 2009). These aforementioned
studies suggest a critical role of Shh signaling in cytogenesis and
development. Likewise, there is growing evidence to suggest
that Shh can stimulate hematopoietic cells to enter the cell
cycle by up-regulating the expression of D-type cyclins required
to pass the G1 restriction point (Mill et al., 2003; Mandal et al.,
2007). Despite extensive studies on shh biofunctions, very
little is known to date about the effect of Shh on the de-
differentiation of astrocytes. Similarly, our more recent studies
strongly suggest that the underlying mechanism of astrocyte
de-differentiation and the transitional rejuvenation processes
is intimately linked with certain appropriate molecules re-
leased from injured astrocytes (Lang et al., 2004; Itoh et al.,
2006; Yang et al., 2009, 2010, 2011). The details of the
effectors of astrocyte de-differentiation and the underlying
molecular mechanism that contributes to the event are still
unknown. In this study, we sought to determine the extent of
ACM to induce astrocyte to reversion to NSPCs. We found that
up-regulation of Shh expression in astrocytes after mechanical
injury may not only contribute to the astrocyte rejuvenation
process, but is also very important for establishment and main-
tenance of NSPCs. The latter finding is consistent with previous
studies (Beachy et al., 2004; Ahn and Joyner, 2005; Palma et
al., 2005). Furthermore we demonstrated that occurrence of
this complex event still depends upon the synergistic action
of other molecules signaling in ACM, implying existence of a
complementing molecular mechanism underlying astrocyte
de-differentiation.
In the present study, we used an in vitro model system to
observe the changes of phenotypic fate of astrocytes under
different treatments. These data indicate that the elevation
of Shh production in mechanically-insulted astrocytes plays a
crucial role in the de-differentiation of astrocyte as Shh
biofunction depletion by its neutralizing antibody markedly
inhibits astrocyte reversion to NSPCs. Application of shh aloneto cultured astrocytes hardly results in a marked change of
relevant specific proteins (GFAP and S100 for astrocyte; nestin,
SOX2 and CD133), implying that the de-differentiation event
still depended upon other signal molecules found in ACM
besides Shh. Furthermore, some critical downstream signal
molecules, like Gli2 and D1-type cyclin, involved in the disrup-
tion of cell-cycle G1 arrest, cell proliferation, cell morphology
change, and cell differentiation are activated. The present
study may lay a foundation for the clinical application of these
molecules to astrocyte de-differentiation in treating CNS injury.Materials and methods
Reagents and antibodies
Dulbecco's modified Eagle's medium (DMEM) with 6 mg/ml
glucose, Dulbecco's modified Eagle's medium/F12(DF12), G5,
D-Hanks, normal donkey serum, normal goat serum and fetal
calf serum (FCS) were purchased fromGibco (USA). Penicillin G,
streptomycin, glutamine, trypsin, poly-L-lysine (PLL), ethy-
lenediamine tetraacetic acid (EDTA), bovine serum albumin
(BSA), retinoic acid (RA), nerve growth factor (NGF), BrdU and
phosphate-buffered saline (PBS) were purchased from Sigma
(USA). Shh protein peptide, mouse monoclonal antibody
against nestin and rabbit monoclonal antibody against Sox2
were from Abcam (USA). Shh neutralizing antibody, mouse
antibody against anti-β-tubulinIII, and mouse monoclonal
antibody against Shh were from Santa Cruz. (USA). Mouse
monoclonal antibody against Glc, rabbit monoclonal antibody
against CD133, rabbit polyclonal antibody against GFAP, S100
and γ-tubulin were from Chemicon (USA). BrdU antibody and
Cyclin D1 antibody were from Millipore (USA). A DAPI staining
kit, cy5-conjugated antibody, Fluor488-conjugated donkey
anti-mouse IgG and Fluor594-conjugated goat anti-rabbit
(molecular probe) were purchased from Molecular Probes
(USA). The RNA isolation kit was from Promega (USA); The BCA
kit, and RNeasymini kits were fromQiagen (Germany); the RT-
PCR kit was purchased from Takala (Japan). The chemilumi-
nescence western blotting kit was purchased from Plus; ELISA
kit for Shh was from UScn life science Inc. Cell culture plates,
dishes, coverslips, and flasks were purchased from Nuncon
(Denmark).Model of mechanically-injured astrocytes and
collection of ACM
Astrocytes were obtained from rat spinal cord of 15-day SD
rats as described previously (Yang et al., 2006). In brief, the
mid-cervical to lumbar portions of spinal cord tissues were
dissected in D-Hank's balanced sodium salts without Ca2+ and
Mg2+, cut into pieces, digested and pipetted to generate
single cell suspension. Cells were then plated at a density of
3×106 cells/25-cm2 plastic flask coated with PLL, and main-
tained in 4 ml DMEM containing 20% FCS, supplemented with
2 mM glutamine, 25 mMHEPES, 50 U/ml penicillin and 50 μg/ml
streptomycin. The culture medium was refreshed once every
3 days. After 2 weeks of culture, purification of astrocytes
was undertaken. Subsequently the purified astrocytes were
digested and re-plated at a density of 5×105 cells/cm2 onto
PLL-coated 6-well culture plates or plastic coverslips.
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containing 10% FCS and used for experiments.
The wound model was developed according to Yang et al.
(2009). As for astrocyte conditioned medium (ACM), the
astrocyte cultures were rinsed and then renewed with DF12
supplemented with G5 prior to scratch-wounding. Scratched
cultures were then maintained for 1, 3, 5 and 7 days in vitro
(DIV), respectively. The supernatant at various points were
subsequently harvested, centrifuged, filtered and finally stored
at −80 °C for the following experiments.
Treatments of cultures
To examine if astrocyte de-differentiation was mainly caused
by Shh signaling from injured astrocyte, cultured astrocytes
were firstly divided into the following groups, normal astrocytes
with treatment of ACM, normal astrocytes with treatment of
ACM plus Shh neutralizing antibody (10 μg/ml in D/F12), normal
astrocytes with treatment of Shh alone (150 nM in dissolved in
DMSO/DF/12), and normal astrocytes without treatment of
exogenous agents. Cells were then processed for the following
different assessments.
Shh ELISA assay
To examine if astrocye de-differentiation wasmainly caused by
Shh signaling, the protein release levels of culture supernatants
of mechanically-injured astrocytes were examined. These
supernatants of the above-mentioned cultures were concen-
trated, and then measured by using high-sensitivity enzyme-
linked immunosorbent assay according to the manufacturer's
instruction (UScn Life Science Inc).
Immunofluorescence
Immunocytochemistry was performed on cells of each exper-
imental group using a slight modification of the procedures of
Weiss et al. (1996). In brief, these cells were fixed with 4%
paraformaldehyde for 20 min and washed three times succes-
sively with phosphate buffered saline (PBS, pH 7.4). For double
labeling, cells were incubated with the primary antibodies
diluted in PBS containing 5% normal goat/donkey serum and
0.01% Triton-X100 at the same time at 4 °C overnight. Dilutions
and other details concerning antibodies are available on
request. For these studies, the following primary antibodies
were used: Shh, GFAP, β-tubulinIII, Glc, Nestin, and Cyclin D1.
After washing, cells were incubated with the corresponding
secondary antibody of Fluorescein-conjugated IgG and DAPI at
room temperature for 60 min. After washing, the cells were
mounted with Fluorsave. The numbers of immunoreactive cells
and total cells per each field were counted over 200 fields (five
coverslips, 15 random fields per each coverslip) after capturing
each image by a confocal laser-scanningmicroscope (Fluoview,
Olympus). Each immunoreactive cell was counted only when
the nucleus was detectable on the 200 field investigated.
Western blotting analyses
For analysis of protein changes after ACM treatment (GFAP,
S100, Nesin, SOX2, and CD133), the total cellular extractswere prepared as follows: the cells in 35-mm dishes were
carefully rinsed with 0.01 M PBS, and extracted in ice-cold
RIPA (50 mM Tris–HCl, pH7.2; 10 mM EDTA; 0.1% (w/v) SDS;
1% (w/v) sodium deoxycholate; 1% (v/v) Triton X-100; 0.6%
(w/v) PMSF; 100 U/ml Trasylol; 2 μg/ml leupetin; 100 μM
sodiumorthorandate) lysis buffer. Cells were scraped off and
collected, and the proteins were then extracted on ice bath
for 1 h after passing through a 27-gauge needle (about 25
times) in 200 μl of the RIPA buffer. Cell lysates were then
clarified and the total protein was determined using BCA
assay (Stoscheck, 1990). Protein lysates were run on 4–20%
gradient SDS-PAGE, respectively, transferred onto nitrocellu-
lose membrane and blocked with 5% fat free milk. Following
this step, the membranes were incubated with the primary
antibodies against the aforementioned antigens, respectively.
For Shh assessment in astrocytes following scratched-wound
injury, the protein blotting procedure is same as the above-
mentioned. γ-tubulin was used as loading control. Subsequent-
ly the next blotting procedures and the digitized images of the
immunoblotting bands were quantitated as described previ-
ously (Yang et al., 2008).
Neurosphere formation
To assess whether astrocyte de-differentiation event was
affected by shh signaling, neurosphere formation in differ-
ent treatment groups were examined and compared. Briefly,
cultured astrocytes of different treatment groups were
dissociated using trypsin–EDTA and a mechanical triturating
by a fire-polished Pasteur pipette, and further single cell
suspensions were collected after filtered through a 60 μm
mesh. Viable cells were assessed using trypan blue exclusion.
Subsequently cells were maintained with D/F12 supplemented
20 ng/ml bFGF, 25 ng/ml EGF, 25 mg/ml glutamine, and 1/2
volume ACM. Cultures were continuously maintained for 7, 10
and 15 days. Neurospheres were counted as previously de-
scribed (Hunt et al., 2010) after cultures were terminated at
each time point. Meanwhile, neurosphere characteristics were
identified by immunostaining for nestin.
Proliferation assay
To determine the effect of Shh in ACM on the proliferation of
de-differentiating astrocytes, BrdU labeling of dividing cells
was performed as described previously by Yang et al. (2009).
Firstly, the neurospheres derived from differentiating astro-
cytes were passaged and further cultured for 8 h prior to
administration of Brdu (4 μM) to each of the different groups.
Subsequently these cells were fixed with 4% paraformaldehyde
for 30 min, and treated with 2 N hydrochloric acid and then
warmed for 30 min at 37 °C to denature DNA for immunostain-
ing at the time of plating for 24 h. Then the Brdu-staining
procedures were completely processed as above-mentioned.
The percentages of Brdu positive cells to total cells of the
examined field (4 coverslips, 15 random fields per coverslip)
were calculated. The experiments were repeated three times.
Cell differentiation assay
For differentiating neurosphere-derived astroglial cells follow-
ing different treatments, neurospheres or cells were treated
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2011). In detail, these neurospheres or cells were re-seeded on
the plastic coverslips coated with 100 ug/ml PLL. They were
subsequently incubated with neurobasal supplemented 2% B27
and 4 μM retinoic acid (RA). Three days later, BDNF (20 ng/ml),
NGF (25 ng/ml) and 2% FCS were added into the cultures to
further promote cell differentiation to fate-determined states.
These cells were then maintained in culture for 2 weeks or
longer, and used for immunocytochemistry.
Quantitative RT-PCR
The expression of Ptc and Gli2 mRNA in cultured astrocytes
following different treatments were analyzed by using
quantitative RT-PCR assay. At the end of cell culture, Total
RNAs of the astrocytes receiving different treatments were
extracted by using RNAeasy Plus purification kit according to
the manufacturer's instructions. GAPDH was used as the
internal control and levels of the targetmRNAswere normalized
against GAPDHmRNA. Twomicrograms of total RNAwas reverse
transcribed to cDNA using the Superscript™ first strand synthesis
system and used for RT-PCR according to the manufacturer's
protocol. The mRNA expression level was quantified by
quantitative PCR using the iCycler iQ™ with SYBR Green
(Molecular Probe). In brief, 1 μl of cDNA was added in a 24 μl
reaction mixture containing 0.5× SYBR Green, PCR buffer,
0.6 μM MgCl2, 0.4 μM dNTP, 0.5 μM primer, and 0.5 U Taq
Polymerase. The reaction condition was 95 °C for 5 min,
40 cycles of 95 °C for 30 s, 58 °C for 30 s, and 72 °C for
1 min). Quantitative PCR was performed in triplicates and
repeated three times. The primer sets used were: Ptc [Fwd,
5′-aacaaaaattcaaccaaacctc-3′, Rwd, 5′-tgtcttcattccagtt-
gatgtg-3′], Gli2: [Fwd, 5′-cgcctggagaacttgaagac-3′, Rwd
5′-ttctcattggagtgagtgcg-3′] and GAPDH [Fwd, 5′-caccatg-
gagaaggccggg-3′, Rwd, 5′-gacggacacattgggggtag-3′]. The PCR
product was visualized by electrophoresis on a 2% (w/v) gel
stained with 0.5 μg/ml ethidium bromide and photographed
under UV light. The gel image was acquired in the Gel Doc 1000
system (BioRad, Hercules, CA) and RT-PCR analysis was carried
out using Quantity One software (BioRad). The integrated
density values (IDV) of the GAPDH standard was used to
calculate the corrected IDV of Ptc and Gli2 products.
Statistics
All data were expressed as Mean±SEM at different time points
for each group. The statistical analysis was performed using
one-way analysis of variance with SPSS10.0 software. *pb0.05
was taken as statistically significant.
Results
Astrocytes following mechanical scratch-injury
up-regulate biologically active Shh protein
To determine whether Shh participates as a key molecule in
de-differentiation of astrocytes, we first detected the changes
of Shh expression in astrocytes following mechanical injury.
As expected, a gradual up-regulation of Shh expression was
observed in astrocytes from 1 to 10 days after injury. Theenhanced immunoreactivity for Shh was widely interspersed
from the scratch margin toward the un-insulted region, and
that the Shh immunoreactivity in astrocytes was progres-
sively elevated with longer culture. Comparatively, day 4
cultures after injury show the most intense Shh reactivity
(Fig. 1A). For normal astrocytes, no Shh immunoreactivity
was detectable (Fig. 1A-ctr). Consistently, the Shh protein was
further verified by western blot analysis of injured astrocyte
lysates. A significant increase in Shh level in astrocytes was
found at various time points after injury, whereas in the control
astrocytes, Shh expression is hardly detectable (Fig. 1B).
Quantitative analysis of western blotting demonstrated that
there was a significant difference in Shh levels at various
time points (Pb0.05 and Pb0.001, Fig. 1C). To determine if
astrocytes also released biologically-active Shh after mechan-
ical injury, ACM was further examined by ELISA assay. The
amount of Shh protein in ACM was 2.5–5-folds greater than in
the supernatant of normal astrocytes, respectively (pb0.05
and pb0.001, Fig. 1D).
The ACM progressively induces expression of NSC
specific makers
Next, we treated the asctrocytes with ACM and performed
western blot assay. The results showed that ACM induces a
constant increase of nestin, Sox2 and CD133 (NSPC specific
markers) in astrocytes from 1 to 10 DIV, while a progressive
decrease of GFAP and S100 expression occurs (Fig. 2A).
Quantitative analysis also showed the densitometry values for
three NSCs' protein levels gradually increased, whereas the
level of the specific protein markers for astrocytes steeply
decreased at the corresponding time points (Fig. 2B). Consis-
tently, immunocytochemistry demonstrated that astrocytes
gradually acquired NSC-like profiles after ACM treatment,
displaying a marked up-regulation of nestin expression in
astrocytes at various time points (Fig. 2C). For the control
astrocytes (normal astrocytes without any treatments), the
above-mentioned three markers for NSCs cannot be detected
except stable expression of GFAP and S100 (Fig. 2D). Nestin
reactivity cannot be detected (Fig. 2E).
Blockade of Shh signaling significantly prevents the
de-differentiation of astrocytes into neural stem cells
The addition of ACM to astrocyte cultures results in a complete
retraction of their extension and a gradual switch to a round
cell type within 10 days, and occasionally the onset of small
neurosphere-like aggregate formation was observed (Fig. 3A-
ACM panels). No significant cell morphology change was found
when the astrocyte culture was treated with ACM in the
presence of Shh neutralizing antibody 5DIV, and only a few
cells exhibit a slight change in morphology in 10 DIV (Fig. 3A-
with Shh n-Ab panels). When Shh protein alone was adminis-
tered to normal astrocytes, we can hardly see any cell mor-
phological changes (Fig. 3A-with Shh panels). The data suggest
Shh signaling mediated astrocyte de-differentiation is depen-
dent on other molecules in ACM.
To further confirm whether Shh signaling as an important
molecule and other molecules synergistically induces astro-
cyte de-differentiation, a Shh n-Ab was administered to the
astrocyte cultures to abolish Shh signaling in ACM. The
Figure 1 Changes of Shh expression in scratch-wounded monolayers of astrocytes. (A) Astrocytes were doubly immunostained for
Shh (red) and GFAP (green) at 1, 4, 7 and 10 days after scratch-wounded insult (blue for DAPI). Of note, cells exhibited strongest Shh
immunoreactivity at 4 days after injury, but no Shh reactivity was detectable in control astrocytes (Ctr) at the corresponding time
points. ※ represents the scratch injury region. Bar=100 μm. (B) Western blot analyses show the changes in Shh expression after
astrocyte injury, γ-tubulin was used as an internal control to normalize for loading differences. (C) Quantitative assessment of
immunoblot of 3 independent experiments. (D) Determination of Shh in the supernatant of injured astrocyte cultures at various times
by in vitro specific ELISA. Notably, a maximal Shh release at 7 days as compared with other time points (**Pb0.001). Data are
reported as Mean±SEM of three independent experiments. *Pb0.05 was used as criterion for the significant difference.
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as astrocyte markers GFAP and S100 were subsequently
detected using western blot assay. Strikingly, the addition of
Shh n-Ab to the cultures for 1, 5, 7, and 10 days in the presence
of ACM markedly inhibited the expression of NSC marker
proteins even though for most of the time points, only a slight
elevation was detectable. In addition, no significant decrease
of GFAP or S100 levels was observed with the lapse of time, as
revealed by the relative optical density analysis (Figs. 3B and
C). Surprisingly, the addition of Shh protein alone to the
astrocyte cultures also has no impact on the above-mentioned
marker peptide (Figs. 3D and E). These observations support
the notion that Shh is essential for de-differentiation of
astrocytes, but its effect is not independent of the activity of
other molecules.Effect of Shh depletion on neurosphere development
and cell proliferation
To further investigate if Shh is essential for astrocyte reverting
back to a less differentiated state, we examined the progenitor
cell potential of neurosphere-forming cells (nestin immunos-
taining). After 5–15 days, ACM-treated astrocytes promptly
developed large neurospheres, whereas few neurospheres or
smaller neurospheres were seen in the cultures in the pres-
ence of Shh n-Ab (Fig. 4A). For normal astrocyte cultures, no
neurosphere-like structure was observed (no data shown). In
agreement with the gradual decline in the expression of NSPC
markers, the blockade of Shh signaling by addition of the Shhn-Ab markedly inhibited the formation of neurospheres, and
their numbers were 3–6 times fewer that in the ACM-treated
sister cultures (Fig. 4B).
In a cell proliferation assay, the administration of Shh n-Ab
to astrocyte cultures in the presence of ACM resulted in a 3.2–
6.5-fold decrease in the number of Brdu+ cells as compared
with ACM-treated groups within four durations, respectively
(Figs. 4C and D).
NSPCs differentiation
Next we determined whether the neurospheres derived from
ACM/or ACM plus Shh nAb-treated astrocytes possess the
pluripotency differentiation ability. We applied NSC differ-
entiation medium to induce the neurospheres, and identi-
fied them by immunocytochemistry as above-described. We
found that after induction of NSCwith a differentiationmedium
for 15 days, the neurospheres derived from ACM-treated
astrocytes differentiated into GFAP+ astrocytes, β-tubulinIII+
neurons (arrows) and Glc+ oligodendrocytes (arrowheads)
(Figs. 5A, B and E), and their percentage was 72.7±12.6%,
9.1±2.9% and 17.5±3.2%, respectively. Whereas in the ACM
plus Shh nAb-treated astrocyte group, only GFAP+ astrocytes
(91.1±15%) and Glc+ oligodendrocytes (arrowheads) (7.9±
3.1%) were observed, but no neurons were found (Figs. 5C,
D and E). For Shh alone treatment and normal groups, no
neurophere generation was found, and thus suchmultipotency
cannot be found (data not shown), suggesting that Shh is able
to change the astrocyte differentiation fate dependent on
other molecules in ACM.
Figure 2 The supernatant of mechanically injured astrocytes (ACM) progressively induces expression of NSPC specific makers. (A) The
immunoblot analysis shows the changes in expression pattern of astrocytemarkers and NSPCmarkers after treatment with ACM, and their
change tendency is depicted with a quantitative analysis of curve (B). (C) Double immunostaining of nestin (red) and GFAP (green) shows
that ACM-treated astrocytes gradually acquired the NSPC characteristics. For normal astrocytes, apart from astrocyte markers, no NSPC
markers were detectable (D). Similar results were revealed by immunoblot analysis (E). Blue for DAPI. Bar=10 μm.
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involved in the astrocyte de‐differentiation
mechanism
Effect of ACM on Ptc expression level
Shh signaling is initiated by the binding of Shh to its receptor
Ptc, which releases the receptor Smo and thus activates an
intracellular signaling cascade, suggesting that Ptc expression
level is directly related to activation of downstream intracel-
lular signaling. Accordingly, the downstream targets activated
by up-regulated Shh expression should be identified. To exam-
ine if Shh is involved in the regulation of Ptc gene expression,
PtcmRNA expression in ACM-treated astrocytes in the presence
or absence of Shh nAb in culture was determined by using
quantitative RT-PCR analysis. As shown in Figs. 6A–B, ACM
treatment significantly increased the levels of Ptc mRNA in
astrocytes at all 3 time points, and Ptc mRNA expression level
remained significantly higher than that in ACM plus Shh nAb
treatment, Shh alone(+) treatment and Shh (−) normal
control. As for Ptc mRNA level in ACM plus Shh nAb-treated
atrocytes, there is no significant difference in the levels of Ptc
mRNA (pN0.05) when compared to normal control groups. Shhalone (+) protein treatment does not result in an increase of
Ptc expression level at any of 3 time points observed.
Gli2 activation
Gli2, an important transcriptional activator, plays a critical
role in the signaling pathways involved in cellular reprogram-
ming, changes of cell cycle and progenitor renewal (Mill et al.,
2003; Beachy et al., 2004; Lee et al., 2011). We thus
investigated the Gli2 expression in astrocytes after the
aforementioned different treatments. RT-PCR indicates that
Gli2 mRNA level in ACM-treated astrocytes was markedly
elevated at all 3 time points (1, 5, and 10 days), and there
was significant difference in the amount of Gli2 mRNA when
compared with astrocytes under other treatment conditions
(ACM plus Shh nAb-treated, Shh-treated, and normal). Although
Gli2 expression was also observed in Shh-treated astrocytes,
there is no significant difference compared with normal control
(Figs. 6C–D).
Cyclin D1
Nextweexamined the changes of Gli2 downstream signaling
molecule, Cyclin D1. As expected, following ACM treatment for
Figure 3 Blockade of the Shh signaling significantly prevent the de-differentiation of astrocytes into NSPCs. (A) ACM can induce
astrocyte morphology change, gradually displaying a round shape (arrows) even neurosphere-like colony (arrowhead), while the
administration of neutralizing antibody against Shh to culture exposed to ACM markedly inhibits above-mentioned change. Also, the
addition of Shh alone to astrocyte culture has no influence on astrocyte morphology. Bar=20 μm (B) western blot analyses further
demonstrated that the administration of neutralizing antibody against Shh does not cause a progressive decrease of the astrocyte
markers GFAP and S100 levels, either a marked increase of NSPC markers (nestin, Sox2 and CD133) in astrocytes exposed to ACM, as
revealed by relative optical densitometry analysis (C). Similar data were obtained from Shh alone treatment (D and E).
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ity for Cyclin D1(37.41±2.67%), whereas blockade of Shh
signaling by Shh n-Ab leads to a significant decrease of Cyclin
D1+ cells (20.44±2.82%). Although there are some Cyclin D1+
cells in shh-treated and control atrocytes, the percentageFigure 4 Depletion of Shh signaling can cause a significant decr
administration Shh n-Ab in the presence of ACM significantly declined
time points, as revealed by statistical analysis (B). Similarly, the de
total BrdU incorporation (green for GFAP, red for BrdU, bar=25 μm)
experiments. *Pb0.05 was used as criterion for the significance of dof Cyclin D1+ cells were very lower compared with ACM treated
group (Figs. 6E and F). Similar to immunocytochemistry,
western blotting analysis showed markedly elevated Cyclin D1
expression in ACM-treated astrocytes, whereas Cyclin D1
protein level in ACM-treated astrocytes in the presence of Shhease in neurosphere formation and cell proliferation. (A) The
neurosphere formation (green for nestin, bar=50 μm) at various
pletion of Shh signaling in ACM results in a marked decrease in
(C and D). Data are reported as Mean±SEM of thrice independent
ifference.
Figure 5 The in vitro multipotency of neurospheres derived from astrocytes with different treatments. After a 15-day induction,
neurospheres derived from ACM-treated astrocytes can differentiate into neurons, astrocytes, and oligodendrocytes. Overlay images
show β-tubulinIII+ (red, arrows) neuron and GFAP+ (green) astrocyte (A), Glc+ (purple, arrow heads) oligodendrocyte and GFAP+
(green) astrocyte (B). For neurospheres derived from astrocytes treated with ACM plus Shh nAb, Overlay images show GFAP+ (green)
astrocyte and Glc+ (red, arrow heads) oligodendrocyte only (C and D). Of note, blue for DAPI. For Shh alone treated or normal
astrocytes, no data were shown for neurosphere formation. Bar=50 μm. (E) Quantification of cell differentiation in neurospheres
from different treatment groups. Data represent percentage of cells immunostained for neuron (β-tubulinIII+), astrocyte (GFAP+),
and oligodengrocyte (Glc+) markers over total number of cells in culture±SEM.
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cantly elevate Cyclin D1 level when compared to normal
astrocytes (Figs. 6G and H). Optical densitometry analysis
further demonstrated that shh alone is insufficient to elevate
the levels of Cyclin D1 expression.Discussion
Our recent experiments demonstrated that astrocytes can
revert to a less differentiated state and become multipo-
tential progenitor cells, and the underlying mechanism ofastrocyte de-differentiation event is intimately linked to the
secreted of certainmolecules by injured astrocytes (Lang et al.,
2004; Yang et al., 2009, 2010, 2011). Similar to our findings,
several previous studies revealed that astrocytes possess a
potential of de-differentiation to neural progenitors, and that
certain extrinsic signaling molecules from nerve microenvi-
ronment after injury contribute actively to its rejuvenation
process (Duggal et al., 1997; Kaya et al., 1999; Dai et al., 2001;
Chang et al., 2007; Sharif et al., 2007; Jiao and Chen, 2008;
Buffo et al., 2008; Jopling et al., 2011). Despite an increasing
evidence for mature astrocytes transformation to a glial pro
phenotype, it is still elusive what triggers the astrocyte de-
Figure 6 Shh and other molecules in ACM synergistically regulate relative molecule signaling-mediated astrocyte de‐differentiation.
(A) RT-PCR analysis of Ptc mRNA levels in the astrocytes treated with ACM, ACM+Shh n-Ab, and Shh protein or without any treatment for
different durations (1 day, 5 days, and 10 days), respectively. (B) The quantification of the Ptc transcript value is the ratio of densitometric
scores for Ptc PCR products (Ptc mRNA expression were normalized to GAPDH mRNA). Results are obtained from three independent
experiments. *Pb0.05 was used as criterion for the significant difference. (C, D) RT-PCR analysis of Gli2 mRNA levels in the astrocytes after
different treatments. (E) Immunofluorescence labeling of astrocytes for Cyclin D1 following different treatments, depicting the synergistic
effect of Shh and othermolecules in ACM on cell characteristics. Bar=50 μm. (F) Quantitative analysis of the percentage of Cyclin D1+ cell in
cultures after different treatments. Data are expressed as Mean±SEM (n=3, each an average of four coverslips with cells counted in 15
randomly chosen). (G) Immunoblotting of Cyclin D1 expression in astrocytes treated with aforementioned treatments indicates Shh and
other molecules in ACM synergistic action in up-regulation of Cyclin D1 expression at the protein level. (H) Quantitative analysis of western
blotting results. Data are reported as means±SEM of three independent experiments (**Pb0.01).
164 H. Yang et al.differentiation event following mechanical injury. Further-
more, there remains considerable interest in elucidating the
possible molecular mechanism of astrocyte de-differentiation.
In this study, we have demonstrated that up-regulated
Shh and other molecules in injured astrocytes synergistical-
ly induces de-differentiation of GFAP-expressing astrocytes
to NSCs, as demonstrated by the dramatic changes in cell
morphology, proliferation rate, and gene expression pat-
tern in cultured astrocytes after treated with ACM. The de-
differentiation process can be depleted by blocking the Shh
action, while Shh protein alone is also insufficient to stim-
ulate astrocyte rejuvenation. Furthermore Shh cooperated
with other signaling molecules in the activation of Ptc and
downstream pathway molecule, Gli2. The transcriptional
regulation of cyclin D1 controls astrocyte cell cycle and cell
phenotype, finally resulting in the reversion of astrocytes to
NSCs.Our in vitro analyses first showed that astrocytes following
mechanical injury markedly increase Shh expression, display-
ing higher levels of Shh synthesis and release as revealed
by immunocytochemistry, western blot and ELISA. The up-
regulation of Shh in injured astrocytes implies that the Shh
signaling molecule may contribute to the activation neurogen-
esis. Shh is known to be an essential regulator of cell fate and
number in the CNS, and also acts as a mitogen, promoting cell
proliferation in many embryonic and adult tissues including
the epidermis and the CNS. Furthermore, Shh signaling is
involved in the formation and/or maintenance of progenitor
cells in the epithelia of many internal organs (Bitgood and
McMahon, 1995; Beachy et al., 2004), of adult hematopoietic
stem cells (Kondo et al., 2005; Mandal et al., 2007), and of
neural stem cells in the adult brain (Palma et al., 2005;
Buffo et al., 2005; Jiao and Chen, 2008; Huang et al., 2010).
Consistently, more recent studies implicate that Shh as an
165Sonic hedgehog released from scratch-injured astrocytes is a key signalimportant factor of the astrocyte-produced neurogenic
niche within several limited areas, suggesting Shh exerts
critical effect in the formation of progenitor cell-derived
from astrocytes (Ahn and Joyner, 2005; Jiao and Chen, 2008;).
Accordingly, we speculated that elevated Shh in ACM is
essential for the reversion of astrocytes into neural progenitors.
As expected, western blot and immunocytochemistry revealed
that the up‐regulation of NSC markers nestin, CD133, and Sox2,
elicited by ACM treatment is indicative of multipotent cells
while astrocyte markers GFAP and S100 markedly down-
regulated. Next to further substantiate if Shh plays a prominent
part in induction of astrocyte de-differentiation, we adminis-
tered Shh protein alone to astrocyte cultures, or neutralized
endogenous Shh in ACM to abolish its biofunctions, respectively.
Surprisingly, neither administration of Shh alone nor blocking
of endogenous Shh in ACM can result in the down-regulation of
astrocyte markers and the up-regulation of NSC markers men-
tioned above. No markedly gradual morphology change can
be observed either, implying that astrocyte may undergo
de-differentiation to NSCs with cooperation between Shh and
other signaling molecule in ACM.
Although Shh depletion does not result in a marked up-
regulation of NSC markers, we still observed little morphology
change and a slight elevation of NSC markers, which prompted
us to further investigate the involvement of Shh signaling in
neurosphere formation and cell proliferation. Strikingly, block-
ing of endogenous Shh in ACM dramatically inhibits neurosphere
formation and cell proliferation, while the administration of
Shh alone to astrocyte cultures does not result in neurosphere
generation. These data therefore provide the first evidence of
the exciting possibility of directly activating astrocyte de-
differentiation though this potential seems to be dependent
on other molecule compensating signaling pathways. Of course,
it is necessary to deliver these signaling molecules (released
from scratch-injured astrocytes) to astrocyte cultures to further
verify this issue even though our data presented here have just
elucidated that these signaling molecules are crucial for the de-
differentation process. However, what molecules and Shh
synergistically provoke this astrocyte de-differentiation is still
unknown. Therefore seeking these molecules is more important
to clarify the underlying mechanisms of this de-differentiation
caused by these molecules.
In this study, we demonstrated that astrocytes exposed to
ACM undergo de-differentiation to multipotent NSPCs which
can re-differentiate into neurons, astrocytes, and oligoden-
trocytes. Whereas blockade of Shh biological functions in ACM
does not result in astrocyte de-differentiation to multipotent
NSPCs (because they can only differentiate into astrocytes and
oligodentrocytes) even though they also form neurosphere-
like structures. The differentiation diversity may be largely
due to distinct properties of neurosphere-forming cells and
the distinct phenotype of neurosphere cells. This result
revealed that lack of Shh signaling may be insufficient to
enhance astrocyte reprogramming and enter a truly less
differentiated state. Rather, they only generate intermediate
or more restricted precursor cells such as glial-restricted
precursor cells, oligodendrocyte precursor cells, and O2A glial
progenitors. It has been documented that astrocytes could not
de-differentiate fully into NSCs directly when induced under
appropriate signal molecules, rather they might undergo
progressive rejuvenation (Dai et al., 2001; Buffo et al., 2005;
Sharif et al., 2007). In corroboration of the assumption in thepresent study we further conducted the examination of
multiple signaling pathway components Ptc, Gli2, and Cyclin
D1 expression in the considerable complicated event. Our data
suggest that Shh has a synergistic effect with other molecule
signaling in ACM on Ptc expression, since elevation of Ptc
expression greatly enhances Shh signal transduction to Gli2 by
a protein complex composed Fu, SuFu, Cos-2, and cytoskele-
tons which further regulates transcription of certain mole-
cules such as ErbB2,Wnt1 and Bmi1 (Liu and Rao, 2004; Sher et
al., 2011; Yang et al., 2011). These molecules are intimately
linked to cell reprogramming, disruption of cell cycle arrest,
cell cycle re-entry, and cell lineage specification. The above‐
mentioned events occur through up-regulation of Cyclin D1
mRNA and protein levels, which allow mature cells to de-
differentiate and subsequently re-enter the cell cycle. The
important downstream molecule of Gli2 transcriptional acti-
vator thus was further examined. Coincidentally, immunocy-
tochemistry and western blot analyses showed Cyclin D1
expression patterns are similar to that of Gli2. Cyclin D1 was
up-regulated in ACM-treated astrocytes. In contrast, the ad-
ministration of Shh n-Ab to the astrocytes in the presence of
ACM failed to result in any significant increase of Cyclin D1. Of
note, Shh alone also cannot result in the up-regulation of
Cyclin D1 expression either. These data imply, but do not
prove, that other molecules in ACM may be required for the
induction of conversion from astrocyte to NSCs.
Collectively, this study has evidenced that apart with Shh
signaling, there is involvement of multiple molecular sub-
groups in the reversion of astrocyte to the un-differentiated
states, implying that there could be numerous mechanisms
that lead to astrocyte de-differentiation in vitro. The com-
plete conversion of astrocytes to NSPCs could still be due to
acquisition of additional unknown signaling compensations
besides Shh responsible for activation of molecule pathways
in astrocyte rejuvenation. Therefore it is extremely impor-
tant to seek these molecules for induction of astrocyte de-
differentiation into NSPCs. Therefore, the present findings
have important implications for neural progenitors of astrocyt-
ic origin as one of the most promising alternative sources for
autologous transplantation for clinical repair of CNS deficits.Disclosure statement
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